Isis

A few weeks ago I gave a presentation in my seminar class on the company Isis Pharmaceuticals. I chose this company because they have a unique and innovative way of treating rare and severe diseases. They use antisense technology to target mRNA that would normally be translated into a protein that is thought to be the cause of a particular disease. This upstream method of treatment has been quite successful and the company currently has two drugs that are on the market with many others in phase two and three clinical trials. Here's a quick link to their website where you can learn more about what it is exactly that they do.  https://www.isispharm.com/about/

With the recent attacks happening in Paris and the numerous other terror-related events occurring worldwide, the word Isis has been on a lot of people's minds. The term, which was chosen by this pharmaceutical company over 20 years ago, has developed more than one connotation in recent years -not all of which are entirely pleasant either. In light of everything happening, I would like the biotech community to continue to recognize and support Isis Pharmaceuticals for all of their hard work and the brilliant discoveries they have made over the last couple of decades. Take the time to do a little research on the company, I promise you'll learn something new. It's the type of place I would love to have the opportunity of working at one day.